Executive Director Rebecca Li joined 2018 Innovative Approaches to Clinical Biomarker Validation conference as a presenter, demonstrating for the attendees the tools Vivli provides to assist in this critical research. The one-day conference, co-hosted by PORTAL, the Harvard Medical School Center for Bioethics, and the Harvard Program in Therapeutic Science, reviewed promising initiatives such as the Vivli platform, and the roles these initiatives can play in driving forward the use of biomarkers in clinical research. Dr. Li introduced Vivli as an innovative platform for sharing and analyzing IPD, including biomarker data.